This new study from India investigated outcomes as they pertained to preterm birth, low birth weight, and infant growth measures up to 1 year post delivery.
The inflammatory markers interleukin (IL) 17A and IL-1β as measured during the third pregnancy trimester were associated with adverse pregnancy- and birth-related outcomes among a cohort of pregnant patients living with or without HIV who received antenatal care at Byramjee Jeejeebhoy Government Medical College (a referral center for HIV care) in Pune, India. This indicates a need for interventions that aim to ameliorate pregnancy-related inflammatory pathways and improve birth-related and infant growth outcomes, the authors emphasized.
These findings were published in December in JAMA Network Open.
“Pregnancy is characterized by major changes in maternal immunity, with an immunosuppressive and anti-inflammatory profile in midpregnancy to late pregnancy compared with a more proinflammatory profile during labor,” the authors wrote. “Alterations to this profile have been associated with adverse pregnancy and birth outcomes.” Specifically, they noted that although much is known of the influence of IL-6, tumor necrosis factor (TNF), IL-1β, and C-reactive protein (CRP) on pregnancy-related outcomes, few data exist on how other inflammation biomarkers may affect these outcomes.
After analyzing data on 218 mother-infant pairs (mean [interquartile] mother age, 23 [21-27] years; gestation, 13-34 weeks at enrollment) from pregnancy through 1 year post partum, who received care between June 27, 2016, and December 9, 2019, they found the following:
The inflammatory markers indicated above—in addition to soluble CD163, soluble CD14 intestinal fatty acid–binding protein, CRP, alpha 1-acid glycoprotein, interferon β, interferon γ, IL-1β, IL-6, interleukin 13, IL-17A, and TNF were also performed on these—were chosen because they are known to influence birth outcomes and HIV status, the authors noted, with the aORs noted above including influences of maternal age, mid upper arm circumference (MUAC), smoking status, HIV status, parity, and PTB history.
Additional findings show that 34% of the women lived below India’s poverty line, 24% had an educational level of primary school or less, 28% were classified as undernourished based on their MUAC, and 8% had a history of PTB.
Primary outcomes for this longitudinal cohort study were PTB delivery, with secondary outcomes being LBW and measures of infant growth (length-for-age, weight-for-age, and weight-for-length z scores) taken at delivery and 6 weeks and 3, 6, and 12 months post partum. Of the entire patient cohort, 69 of the mothers were living with HIV. In addition, ultrasonography confirmed gestational age of pregnancy.
“These results suggest a need for future studies to test whether modulating specific inflammatory pathways (eg, those associated with the inflammasome pathway or the TH17 pathway) could be associated with birth outcomes and growth deficits,” the authors wrote. “If these findings are confirmed, future studies should identify and test such an intervention for improved maternal-infant health outcomes.”
Additional future studies, they determined, should investigate the influence of circulating levels of IL-17A on PTB and LBW, as well as the ability of infants born with lower length-for-age and lower weight-for-age z scores to mothers living with HIV to partially recover from those deficits.
“This study examines multiple inflammatory markers, providing insights into different inflammatory pathways associated with general inflammation, monocyte activation, gut integrity, and inflammasome activation,” the authors concluded. “As most existing research on some of these inflammatory markers and PTB have been conducted in Western countries, our study provides valuable data from India with its unique immune, metabolic, and nutritional profile.”
Reference
Shafiq M, Mathad JS, Naik S, et al.Association of maternal inflammation during pregnancy with birth outcomes and infant growth among women with or without HIV in India. JAMA Netw Open. Published online December 22, 2021. doi:10.1001/jamanetworkopen.2021.40584
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More